Singular Genomics Systems, Inc. [Rocket]

In millions, except per share items	Dec-31-22	Dec-05-22	Dec-31-21	Dec-05-21	Dec-31-20	Dec-05-20	Dec-31-19
	10-K	8-K	10-K	8-K	10-K	8-K	S-1/A
Revenues	0.8	0.8	0.0	0.0	0.0	21.2	10.5
Revenue growth				-100.0%	-100.0%
Cost of goods sold	0.8	0.8	0.0	0.0	0.0	42.5	21.0
Gross profit	0.0	0.0	0.0	0.0	0.0	-21.2	-10.5
Gross margin	1.4%	-3.1%				-100.0%	-100.0%
Selling, general and administrative [+]	47.3	47.3	28.6	28.6	6.3	6.3	2.3
General and administrative							2.3
Research and development	46.2	46.2	32.7	32.7	21.2
Other operating expenses	0.0
EBITDA [+]	-91.1		-60.1		-26.9		-12.4
EBITDA growth	51.4%	52.6%	123.6%	122.6%	116.5%
EBITDA margin	-11382.0%	-12220.5%				-129.6%	-118.5%
Depreciation and amortization	2.4		1.1		0.6		0.4
EBIT [+]	-93.5	-93.5	-61.3	-61.3	-27.5	-27.5	-12.8
EBIT growth	52.6%	52.6%	122.6%	122.6%	115.6%
EBIT margin	-11685.9%	-12220.5%				-129.6%	-121.8%
Interest expense, net [+]	0.8	0.8	0.8	0.8	0.7	0.3	-0.5
Interest expense	0.8	0.8	0.8	0.8	0.7	0.7
Interest income						0.5	0.5
Other income (expense), net [+]	185.1	3.4	160.9	-36.6	0.3	-0.2	0.0
Change in fair value of warrants			-2.2		-0.2
Other	2.6	-2.6	-37.5	37.5	0.0
Pre-tax income	90.9	-90.9	98.8	-98.8	-27.9	-27.9	-12.3
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	90.9	-90.9	98.8	-98.8	-27.9	-27.9	-12.3
Net margin	11359.9%	-11879.6%				-131.5%	-117.6%

Basic EPS [+]	$1.28	($1.28)	$2.10	($2.10)	($2.64)	($2.64)	($1.43)
Growth	-39.2%	-39.2%	-179.5%	-20.5%	84.8%
Diluted EPS [+]	$1.28	($1.28)	$2.10	($2.10)	($2.64)	($2.64)	($1.43)
Growth	-39.2%	-39.2%	-179.5%	-20.5%	84.8%

Shares outstanding (basic) [+]	71.1	71.1	47.0	47.0	10.6	10.6	8.6
Growth	51.3%	51.3%	344.6%	344.6%	22.7%
Shares outstanding (diluted) [+]	71.1	71.1	47.0	47.0	10.6	10.6	8.6
Growth	51.3%	51.3%	344.6%	344.6%	22.7%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.